Andrew R. de Guttadauro
President chez Oncolytics Biotech (U.S.), Inc.
Fortune : 11 140 $ au 30/04/2024
Profil
Andrew R.
de Guttadauro is currently the President & Global Head-Business Development at Oncolytics Biotech (U.S.), Inc. He previously worked as the Senior Director-Strategy at Biogen, Inc. and as the Vice President-Corporate Development at Vical, Inc. from 2007 to 2010.
From 2012 to 2017, he served as the Principal at 1798 Consultants, Inc. Additionally, he held the position of Global Head-Business Development at Oncolytics Biotech, Inc. Mr. de Guttadauro completed his undergraduate degree at the US Military Academy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0,01% | 15/11/2023 | 10 315 ( 0,01% ) | 11 140 $ | 30/04/2024 |
Postes actifs de Andrew R. de Guttadauro
| Sociétés | Poste | Début |
|---|---|---|
Oncolytics Biotech (U.S.), Inc.
 Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Part of Oncolytics Biotech, Inc., Oncolytics Biotech (U.S.), Inc. manufactures pharmaceutical products. The company is based in Half Moon Bay, CA. | President | 29/06/2017 |
Anciens postes connus de Andrew R. de Guttadauro
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Corporate Officer/Principal | 01/12/2023 |
1798 Consultants, Inc.
 1798 Consultants, Inc. Medical/Nursing ServicesHealth Services 1798 Consultants, Inc. operates as a boutique healthcare advisory firm, which specializes in the areas of access, reimbursement, compliance, and commercialization for the biotechnology, pharmaceutical, medical device, and diagnostic industries. Its services include manage markets consulting, compliance, informatics, reimbursement training, and competitive intelligence. The company was founded by Roshawn Blunt in 2005 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/06/2017 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/03/2010 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Formation de Andrew R. de Guttadauro
| US Military Academy | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Oncolytics Biotech (U.S.), Inc.
Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Part of Oncolytics Biotech, Inc., Oncolytics Biotech (U.S.), Inc. manufactures pharmaceutical products. The company is based in Half Moon Bay, CA. | Health Technology |
1798 Consultants, Inc.
1798 Consultants, Inc. Medical/Nursing ServicesHealth Services 1798 Consultants, Inc. operates as a boutique healthcare advisory firm, which specializes in the areas of access, reimbursement, compliance, and commercialization for the biotechnology, pharmaceutical, medical device, and diagnostic industries. Its services include manage markets consulting, compliance, informatics, reimbursement training, and competitive intelligence. The company was founded by Roshawn Blunt in 2005 and is headquartered in La Jolla, CA. | Health Services |